Compare, Analyse Orchid Chemicals with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD vs TEVA PHARMA (Israel) - Comparison Results

ORCHID PHARMA LTD     Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ORCHID PHARMA LTD   TEVA PHARMA
EQUITY SHARE DATA
    ORCHID PHARMA LTD
Sep-13
TEVA PHARMA
Dec-13
ORCHID PHARMA LTD/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1942,967-   
Low Rs352,577-   
Sales per share (Unadj.) Rs276.51,702.7-  
Earnings per share (Unadj.) Rs-79.2106.4-  
Cash flow per share (Unadj.) Rs-43.5244.0-  
Dividends per share (Unadj.) Rs093.11-  
Dividend yield (eoy) %03.4 0.0%  
Book value per share (Unadj.) Rs53.91,891.4-  
Shares outstanding (eoy) m70.45848.00-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x0.41.6 25.4%   
Avg P/E ratio x-1.426.1 -5.5%  
P/CF ratio (eoy) x-2.611.4 -23.2%  
Price / Book Value ratio x2.11.5 144.8%  
Dividend payout %087.5 0.0%   
Avg Mkt Cap Rs m8,0672,350,758 0.3%   
No. of employees `0002.844.9 6.2%   
Total wages/salary Rs m2,5270-   
Avg. sales/employee Rs Th6,956.132,126.4 21.7%   
Avg. wages/employee Rs Th902.50-   
Avg. net profit/employee Rs Th-1,993.02,006.9 -99.3%   
INCOME DATA
Net Sales Rs m19,4771,443,919 1.3%  
Other income Rs m4070-   
Total revenues Rs m19,8841,443,919 1.4%   
Gross profit Rs m1,103395,418 0.3%  
Depreciation Rs m2,519116,713 2.2%   
Interest Rs m5,22728,361 18.4%   
Profit before tax Rs m-6,236250,344 -2.5%   
Minority Interest Rs m201,137 1.7%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m511-164,337 -0.3%   
Tax Rs m-125-3,056 4.1%   
Profit after tax Rs m-5,58090,201 -6.2%  
Gross profit margin %5.727.4 20.7%  
Effective tax rate %2.0-1.2 -164.4%   
Net profit margin %-28.76.2 -458.6%  
BALANCE SHEET DATA
Current assets Rs m11,014975,218 1.1%   
Current liabilities Rs m32,060850,472 3.8%   
Net working cap to sales %-108.18.6 -1,250.7%  
Current ratio x0.31.1 30.0%  
Inventory Days Days9591 104.5%  
Debtors Days Days3496 35.0%  
Net fixed assets Rs m29,440471,616 6.2%   
Share capital Rs m7053,554 19.8%   
"Free" reserves Rs m2,0430-   
Net worth Rs m3,8001,603,920 0.2%   
Long term debt Rs m9,018738,308 1.2%   
Total assets Rs m46,5103,299,818 1.4%  
Interest coverage x-0.29.8 -2.0%   
Debt to equity ratio x2.40.5 515.6%  
Sales to assets ratio x0.40.4 95.7%   
Return on assets %-0.83.6 -21.2%  
Return on equity %-146.95.6 -2,611.3%  
Return on capital %-3.74.9 -75.7%  
Exports to sales %37.90-   
Imports to sales %22.60-   
Net fx Rs m1,8650-   
CASH FLOW
From Operations Rs m1,682230,086 0.7%  
From Investments Rs m-9,860-81,529 12.1%  
From Financial Activity Rs m6,644-276,004 -2.4%  
Net Cashflow Rs m-1,535-127,446 1.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 71.08 Rs / USD

Compare ORCHID PHARMA LTD With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare ORCHID PHARMA LTD With: PFIZER  IPCA LABS  ELDER PHARMA  PIRAMAL ENTERPRISES  STERLING BIOTECH  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views On News

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (4QFY18); Net Profit Up 50.8% (Quarterly Result Update)

Aug 24, 2018 | Updated on Aug 24, 2018

For the quarter ended March 2018, ORCHID PHARMA LTD has posted a net profit of Rs 924 m (up 50.8% YoY). Sales on the other hand came in at Rs 2 bn (down 24.0% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Jul 24, 2019 (Close)

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD 8-QTR ANALYSIS

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS